基本信息 姓 名:王江新 职 称:教授 职 位: 所 属 系:生物技术系 办公地点:丽湖校区守慧楼316 办公电话: 邮 箱:jxwang@szu.edu.cn 工作职责:裸藻研究 个人简介 王江新,男,遗传学博士,亚洲bet57365游戏大厅教授。1996年入中科院水生所学习藻类分类及分子生物学;2002年在巴黎高等师范学校(École Normale Supérieure, ENS,Paris)从事蓝藻蛋白组及生物信息学研究;2004-2014年分别在美国亚利桑那州大学做博士后,涉及微藻环境分子毒理和微藻生物能源研究;亚利桑那州大学生物设计研究所从事系统生物学及合成生物学、单细胞组学研究。迄今,共发表论文110余篇,引用3,633余次,H-index 31(截止2023年3月),以第一发明人拥有中国专利4项,申请专利6项。 2014年加入亚洲bet57365游戏大厅,以裸藻作为主要研究对象,进行基础研究和成果转化。主要从事以下几个方面的研究:1)微藻系统生物学;2)微藻合成生物学。开发高通量的微藻基因组编辑技术,兴趣集中在生物能源及高附加值生物产品(如DHA和虾青素)以及人工合成细胞器;3)单细胞组学。研究方法涉及单细胞的获取、单细胞qRT-PCR、单细胞转录组分析; 4)课题组也致力于各种裸藻功能性活性物质的大规模化生产、提取及终端产品的研发和产业化。 Jiangxin Wang received his PhD degree in Genetics from the Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China in 2003. After graduation he then joined the laboratory of Dr. Jean Houmard at the Department of Biologie at the CNRS-ENS, Paris, in 2003 as a postdoctoral researcher. He also worked at Arizona State University, Tempe, US as a research associate and research scientist from 2004 to 2012. Dr. Wang now is a Professor at the School of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China. His research is focused on bioactive compounds from marine and freshwater microbes and single-celled OMICS. In particular, Dr. Wang is interested in a green protist, Euglena gracilis, and the role of paramylon (beat-1,3-glucan) in the immune system and the possibilities of using paramylon as potential function foods and prodrugs. Dr. Wang is using systems biology and synthetic biology tools to fulfill his academic goals. Also, he is the associate editor of Frontiers in Pharmacology. Dr. Wang currently published 110 peer-reviewed scientific articles, with 31 H-index and total 3,633 citations (until March 2, 2023). 近期发表的论文 Selected publications: Chen, Z., Zhu, J., Chen, Z., Du, M., Yao, R., Fu, W., et al. (2022). High-throughput sequencing revealed low-efficacy genome editing using Cas9 RNPs electroporation and single-celled microinjection provided an alternative to deliver CRISPR reagents into Euglena gracilis. Plant Biotechnol J. doi: 10.1111/pbi.13915. Wu, M., Qin, H., Deng, J., Liu, Y., Lei, A., Zhu, H., et al. (2021). A new pilot-scale fermentation mode enhances Euglena gracilis biomass and paramylon (β-1,3-glucan) production. Journal of Cleaner Production, 128996. doi: https://doi.org/10.1016/j.jclepro.2021.128996. Wu, M., Wu, G., Lu, F., Wang, H., Lei, A., and Wang, J. (2022). Microalgal photoautotrophic growth induces pH decrease in the aquatic environment by acidic metabolites secretion. Biotechnology for Biofuels and Bioproducts 15(1), 115. doi: 10.1186/s13068-022-02212-z. Xie, Y., Li, J., Qin, H., Wang, Q., Chen, Z., Liu, C., et al. (2021). Paramylon from Euglena gracilis prevents lipopolysaccharide induced acute liver injury. Front Immunol. doi: 10.3389/fimmu.2021.797096/. Yao, R., Fu, W., Du, M., Chen, Z., Lei, A., and Wang, J. (2022). Carotenoids biosynthesis, accumulation, functions, and applications of a model microalga Euglena gracilis. Marine Drugs. doi: 10.3390/md20080496. 职称 教授 职位 所属系 生物技术系 办公室 丽湖校区守慧楼316 办公电话 邮箱 jxwang@szu.edu.cn 工作职责 裸藻研究 个人简介 王江新,男,遗传学博士,亚洲bet57365游戏大厅教授。1996年入中科院水生所学习藻类分类及分子生物学;2002年在巴黎高等师范学校(École Normale Supérieure, ENS,Paris)从事蓝藻蛋白组及生物信息学研究;2004-2014年分别在美国亚利桑那州大学做博士后,涉及微藻环境分子毒理和微藻生物能源研究;亚利桑那州大学生物设计研究所从事系统生物学及合成生物学、单细胞组学研究。迄今,共发表论文110余篇,引用3,633余次,H-index 31(截止2023年3月),以第一发明人拥有中国专利4项,申请专利6项。<br><br>2014年加入亚洲bet57365游戏大厅,以裸藻作为主要研究对象,进行基础研究和成果转化。主要从事以下几个方面的研究:<br>1)微藻系统生物学;<br>2)微藻合成生物学。开发高通量的微藻基因组编辑技术,兴趣集中在生物能源及高附加值生物产品(如DHA和虾青素)以及人工合成细胞器;<br>3)单细胞组学。研究方法涉及单细胞的获取、单细胞qRT-PCR、单细胞转录组分析; <br>4)课题组也致力于各种裸藻功能性活性物质的大规模化生产、提取及终端产品的研发和产业化。<br><br>Jiangxin Wang received his PhD degree in Genetics from the Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China in 2003. After graduation he then joined the laboratory of Dr. Jean Houmard at the Department of Biologie at the CNRS-ENS, Paris, in 2003 as a postdoctoral researcher. He also worked at Arizona State University, Tempe, US as a research associate and research scientist from 2004 to 2012. Dr. Wang now is a Professor at the School of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China. His research is focused on bioactive compounds from marine and freshwater microbes and single-celled OMICS. In particular, Dr. Wang is interested in a green protist, <p style="font-style:italic ;display: inline-block;">Euglena gracilis</p>, and the role of paramylon (beat-1,3-glucan) in the immune system and the possibilities of using paramylon as potential function foods and prodrugs. Dr. Wang is using systems biology and synthetic biology tools to fulfill his academic goals. Also, he is the associate editor of Frontiers in Pharmacology. Dr. Wang currently published 110 peer-reviewed scientific articles, with 31 H-index and total 3,633 citations (until March 2, 2023).